Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti-PD-1/PD-L1 Therapies.
Cancer Immunol Res. 2022 Aug 3;10(8):1013-1027. doi: 10.1158/2326-6066.CIR-21-0802.
Cancer Immunol Res. 2022.
PMID: 35679518
The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent.
Grasselly C, Denis M, Bourguignon A, Talhi N, Mathe D, Tourette A, Serre L, Jordheim LP, Matera EL, Dumontet C.
Grasselly C, et al.
Front Immunol. 2018 Oct 9;9:2100. doi: 10.3389/fimmu.2018.02100. eCollection 2018.
Front Immunol. 2018.
PMID: 30356816
Free PMC article.
Item in Clipboard
Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy.
Denis M, Mathé D, Micoud M, Choffour PA, Grasselly C, Matera EL, Dumontet C.
Denis M, et al. Among authors: grasselly c.
Front Immunol. 2023 Jan 10;13:1011943. doi: 10.3389/fimmu.2022.1011943. eCollection 2022.
Front Immunol. 2023.
PMID: 36703964
Free PMC article.
Item in Clipboard
Cite
Cite